CSNK2A2IP
gene geneOn this page
Summary
CSNK2A2IP (casein kinase 2 subunit alpha’ interacting protein, HGNC:53637) is a protein-coding gene on chromosome 3p11.1, encoding Casein kinase II subunit alpha’-interacting protein (A0A1B0GTH6). May play a role in chromatin regulation of male germ cells.
Predicted to be located in male germ cell nucleus.
Source: NCBI Gene 111064647 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 2 total
- MANE Select transcript:
NM_001368165
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:53637 |
| Approved symbol | CSNK2A2IP |
| Name | casein kinase 2 subunit alpha’ interacting protein |
| Location | 3p11.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000283434 |
| Ensembl biotype | protein_coding |
| Entrez | 111064647 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 5 protein_coding_CDS_not_defined, 1 protein_coding
ENST00000635844, ENST00000636323, ENST00000636504, ENST00000636795, ENST00000637986, ENST00000638109
RefSeq mRNA: 4 — MANE Select: NM_001368165
NM_001368165, NM_001368166, NM_001368167, NM_001368168
CCDS: CCDS93323
Canonical transcript exons
ENST00000637986 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003794061 | 88465088 | 88467594 |
| ENSE00003797497 | 88338456 | 88338643 |
Expression profiles
Bgee: expression breadth broad, 56 present calls, max score 88.16.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0246 / max 23.0053, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 37464 | 0.0246 | 3 |
Top tissues by expression
111 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 88.16 | gold quality |
| left testis | UBERON:0004533 | 85.12 | gold quality |
| testis | UBERON:0000473 | 84.59 | gold quality |
| right testis | UBERON:0004534 | 81.44 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 58.82 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 57.50 | gold quality |
| right frontal lobe | UBERON:0002810 | 54.41 | gold quality |
| primary visual cortex | UBERON:0002436 | 53.67 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 52.08 | gold quality |
| cerebellar cortex | UBERON:0002129 | 51.51 | gold quality |
| cerebellum | UBERON:0002037 | 51.27 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 50.20 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 49.87 | silver quality |
| anterior cingulate cortex | UBERON:0009835 | 49.56 | gold quality |
| cerebral cortex | UBERON:0000956 | 49.36 | gold quality |
| substantia nigra | UBERON:0002038 | 48.61 | gold quality |
| hypothalamus | UBERON:0001898 | 47.74 | gold quality |
| colonic epithelium | UBERON:0000397 | 46.47 | gold quality |
| frontal cortex | UBERON:0001870 | 46.24 | gold quality |
| brain | UBERON:0000955 | 45.32 | gold quality |
| amygdala | UBERON:0001876 | 45.08 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 44.88 | gold quality |
| temporal lobe | UBERON:0001871 | 44.86 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 44.13 | gold quality |
| Ammon’s horn | UBERON:0001954 | 44.04 | gold quality |
| nucleus accumbens | UBERON:0001882 | 42.77 | gold quality |
| ventricular zone | UBERON:0003053 | 41.92 | gold quality |
| putamen | UBERON:0001874 | 41.78 | gold quality |
| prefrontal cortex | UBERON:0000451 | 40.87 | gold quality |
| sural nerve | UBERON:0015488 | 39.32 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.93 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Csnk2a2ip | ENSMUSG00000068167 |
| rattus_norvegicus | Csnka2ip | ENSRNOG00000068003 |
Protein
Protein identifiers
Casein kinase II subunit alpha’-interacting protein — A0A1B0GTH6 (reviewed: A0A1B0GTH6)
Alternative names: Casein kinase 2 alpha prime interacting protein
All UniProt accessions (1): A0A1B0GTH6
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in chromatin regulation of male germ cells.
Subunit / interactions. Interacts (via C-terminus) with CSNK2A2.
Subcellular location. Nucleus.
Post-translational modifications. Phosphorylated by CK2 (casein kinase II), specifically by complexes containing catalytic subunit CSNK2A2.
RefSeq proteins (4): NP_001355094, NP_001355095, NP_001355096, NP_001355097 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR038954 | CSNKA2IP | Family |
UniProt features (3 total): chain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A1B0GTH6-F1 | 44.73 | 0.01 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 2 (showing top):
GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_DN, chr3p11
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
100 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CSNK2A2IP | CYLC2 | Q14093 | 547 |
| CSNK2A2IP | RIMS2 | Q9UQ26 | 449 |
| CSNK2A2IP | UTP3 | Q9NQZ2 | 437 |
| CSNK2A2IP | KATNB1 | Q9BVA0 | 405 |
| CSNK2A2IP | DPEP3 | Q9H4B8 | 398 |
| CSNK2A2IP | ZPBP2 | Q6X784 | 389 |
| CSNK2A2IP | CABYR | O75952 | 379 |
| CSNK2A2IP | TRIM52 | Q96A61 | 378 |
| CSNK2A2IP | SPATA16 | Q9BXB7 | 377 |
| CSNK2A2IP | TEX12 | Q9BXU0 | 370 |
| CSNK2A2IP | TSSK2 | Q96PF2 | 370 |
| CSNK2A2IP | NDRG2 | Q9UN36 | 370 |
| CSNK2A2IP | TBPL1 | P62380 | 310 |
| CSNK2A2IP | SPAG1 | Q07617 | 310 |
| CSNK2A2IP | CROCC | Q5TZA2 | 300 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A1B0GTH6, A0A1D5RMD1, A1KXM5, A2AEY4, A6NCI8, A6QQS3, A7KBS4, C4P6S0, O94713, P0C9Z7, P53963, P53976, Q0P670, Q0VAV2, Q10668, Q196W1, Q2KHR3, Q2YDJ5, Q32MG2, Q3V0A6, Q3V3Q4, Q4V8E9, Q5JRM2, Q68FV4, Q6AXV6, Q6AYN3, Q6NS59, Q7TSG5, Q80VJ6, Q80Y39, Q80YD3, Q810T2, Q86XD8, Q8C5U4, Q8CH19, Q8IWI9, Q8K4E0, Q8NDH2, Q8NEV8, Q8NFU7
Diamond homologs: A0A1B0GTH6, Q8CH19
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
2 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
4742 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:88466637:T:A | V427D | 0.981 |
| 3:88466783:T:C | C476R | 0.979 |
| 3:88466865:T:A | V503D | 0.978 |
| 3:88467413:T:C | F686L | 0.978 |
| 3:88467415:T:A | F686L | 0.978 |
| 3:88467415:T:G | F686L | 0.978 |
| 3:88467404:T:A | W683R | 0.976 |
| 3:88467404:T:C | W683R | 0.976 |
| 3:88466785:C:G | C476W | 0.974 |
| 3:88466722:A:C | R455S | 0.973 |
| 3:88466722:A:T | R455S | 0.973 |
| 3:88466781:T:A | V475D | 0.972 |
| 3:88466859:T:A | L501H | 0.968 |
| 3:88466622:T:A | V422D | 0.966 |
| 3:88466700:T:C | L448P | 0.964 |
| 3:88466859:T:C | L501P | 0.962 |
| 3:88466721:G:C | R455T | 0.961 |
| 3:88466688:T:C | I444T | 0.960 |
| 3:88466731:G:C | R458S | 0.960 |
| 3:88466731:G:T | R458S | 0.960 |
| 3:88466853:C:A | A499E | 0.960 |
| 3:88466727:T:C | M457T | 0.959 |
| 3:88467387:T:C | L677S | 0.959 |
| 3:88467406:G:C | W683C | 0.959 |
| 3:88467406:G:T | W683C | 0.959 |
| 3:88467140:T:A | W595R | 0.958 |
| 3:88467140:T:C | W595R | 0.958 |
| 3:88466725:G:C | R456S | 0.957 |
| 3:88466725:G:T | R456S | 0.957 |
| 3:88467414:T:C | F686S | 0.957 |
dbSNP variants (sampled 300 via entrez): RS1000081669 (3:88371227 G>A), RS1000090434 (3:88412051 A>T), RS1000119705 (3:88357291 A>T), RS1000120158 (3:88411760 A>T), RS1000174117 (3:88357022 G>A), RS1000180002 (3:88434059 C>A,T), RS1000218521 (3:88393060 TG>T,TGG), RS1000315603 (3:88405756 C>T), RS1000360972 (3:88439650 G>A), RS1000380581 (3:88362131 T>A), RS1000477825 (3:88418194 T>C), RS1000492731 (3:88373051 C>T), RS1000570553 (3:88393410 A>G), RS1000657392 (3:88352158 G>A,C), RS1000766656 (3:88400977 TAGA>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.